References
- FenterTCNaslundMJShahMBEaddyMTBlackLThe cost of treating the 10 most prevalent diseases in men 50 years of age or olderAm J Manag Care2006124 SupplS90S9816551207
- WelchGWeingerKBarryMJQuality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up StudyUrology200259224525011834396
- RosenRAltweinJBoylePLower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7)Eur Urol200344663764914644114
- HollingsworthJMWeiJTEconomic impact of surgical intervention in the treatment of benign prostatic hyperplasiaRev Urol20068Suppl 3S9S15
- IsaacsJTCoffeyDSEtiology and disease process of benign prostatic hyperplasiaProstate Suppl19892Suppl33502482772
- BarryMJEpidemiology and natural history of benign prostatic hyperplasiaUrol Clin North Am19901734955071695778
- American Urological Association guideline: management of benign prostatic hyperplasia (BPH)2010 Available from: http://www.aua-net.org/common/pdf/education/clinical-guidance/Benign-Prostatic-Hyperplasia.pdfAccessed July 13, 2017
- WeiJTCalhounEJacobsenSJUrologic diseases in America project: benign prostatic hyperplasiaJ Urol200517341256126115758764
- PlatzEAJoshuCEMondulAMPeskoeSBWillettWCGiovannucciEIncidence and progression of lower urinary tract symptoms in a large prospective cohort of United States menJ Urol2012188249650122704110
- AmersonDUroLift for BPH: changing the game in BPH carePaper presented at: AACU State Advocacy ConferenceSeptember 18–19, 2015Chicago, IL
- VuichoudCLoughlinKRBenign prostatic hyperplasia: epidemiology, economics and evaluationCan J Urol201522Suppl 11626497338
- SaigalCSJoyceGEconomic costs of benign prostatic hyperplasia in the private sectorJ Urol200517341309131315758787
- KohJSChoKJKimHSKimJCTwelve-month medication persistence in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasiaInt J Clin Pract201468219720224372906
- CindoloLPirozziLFanizzaCclinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort studyEur Urol201568341842525465970
- NicholMBKnightTKWuJBarronRPensonDFEvaluating use patterns of and adherence to medications for benign prostatic hyperplasiaJ Urol200918152214222119296986
- KaplanSNaslundMPublic, patient, and professional attitudes towards the diagnosis and treatment of enlarged prostate: a landmark national US surveyInt J Clin Pract200660101157116516942587
- EmbertonMMarbergerMde la RosetteJUnderstanding patient and physician perceptions of benign prostatic hyperplasia in Europe: the Prostate Research on Behaviour and Education (PROBE) SurveyInt J Clin Pract2008621182618028388
- Centers for Disease Control and PreventionPublic health and aging: trends in aging – United States and worldwideJAMA2003289111371137312636453
- European Association of UrologyGuidelines on the management of non-neurogenic male lower urinary tract symptoms (LUTS) including benign prostatic obstruction (BPO)2015 Available from: http://uroweb.org/wp-content/uploads/EAU-Guidelines-Non-Neurogenic-Male-LUTS-Guidelines-2015-v2.pdfAccessed July 13, 2017
- MullinsCKaplanSAA new vision for the study of benign prostate disease: the NIDDK Prostate Research Strategic PlanJ Urol2009181396397119150562
- US Department of Health and Human Services, Center for Medicare and Medicaid Services2016MedPAR LDS – Hospital (National). FY2016 MedPAR LDS [Data Set] Available from: https://www.cms.gov/Research-Statistics-Data-and-Systems/Files-for-Order/LimitedDataSets/MEDPARLDSHospitalNational.htmlAccessed June 23, 2016
- McConnellJDRoehrbornCGBautistaOMMedical Therapy of Prostatic Symptoms (MTOPS) Research GroupThe long-term effect of doxazosin, finasteride, and combo therapy on the clinical progression of benign prostatic hyperplasiaN Engl J Med2003349252387239814681504
- RoehrbornCGSiamiPBarkinJCombAT Study GroupThe effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT studyEur Urol201057112313119825505
- McVaryKTGangeSNGittelmanMCMinimally invasive prostate convective water vapor energy (WAVE) ablation: a multicenter, randomized, controlled study for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasiaJ Urol20151951529153826614889
- McVaryKTGangeSNGittelmanMCErectile and ejaculatory function preserved with convective water vapor energy treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: randomized controlled studyJ Sex Med201613692493327129767
- RoehrbornCGGangeSNGittelmanMCConvective water vapor energy ablation therapy: durable two-year results and prospective blinded crossover study for treatment of lower urinary tract symptoms due to benign prostatic hyperplasiaJ Urol201719761507151627993667
- WooHHChinPMcNicholasTASafety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)BJU Int20111081828821554526
- RoehrbornCGGangeSNShoreNDDurability of the prostate urethral lift: 2-year results of the LIFT StudyUrol Pract2015212632
- McNicholasTAWooHHChinPTMinimally invasive prostatic urethral life: surgical technique and multinational experienceEur Urol201364229229923357348
- McVaryKTGangeSNShoreNDTreatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral liftJ Sex Med201411127928724119101
- CantwellALBogacheWKRichardsonSFMulticentre prospective crossover study of the “prostatic urethral lift” for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasiaBJU Int2014113461562224765680
- RoehrbornCGRukstalisDBBarkinJThree year results of the prostatic urethral L.I.F.T. studyCan J Urol20152237772778226068624
- SønksenJBarberNJSpeakmanMJProspective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results of the BPH6 studyEur Urol201568464365225937539
- HindleyRGMostafidAHBrierlyRDHarrisonNWThomasPJFletcherMSThe 2-year symptomatic and urodynamic results of a prospective randomized trial of interstitial radiofrequency therapy vs transurethral resection of the prostateBJU Int200188321722011488732
- MuraiMTachibanaMMikiMShiozawaHHiraoYOkajimaETransurethral needle ablation of the prostate: an initial Japanese clinical trialInt J Urol2001839910511260333
- DaehlinLGustavsenANilsenAHMohnJTransurethral needle ablation for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia: outcome after 1 yearJ Endourol200216211111511962552
- ZlottaARGiannakopoulosXMaehumOOstremTSchulmanCCLong-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centersEur Urol2003441899312814680
- HillBBelvilleWBruskewitzRTransurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trialJ Urol20041716 Pt 12336234015126816
- KimTSChoiSRhewHYComparative study on the treatment outcome and safety of TURP, ILC, TUNA and TEAP for patients with benign prostatic hyperplasiaKorean J Urol20064139
- OhigashiTNakamuraKNakashimaJBabaSMuraiMLong-term results of three different minimally invasive therapies for lower urinary tract symptoms due to benign prostatic hyperplasia: comparison at a single instituteInt J Urol200714432633017470164
- RosarioDJPhillipsJTChappleCRDurability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy failsJ Urol200717731047105117296409
- MalekRSKuntzmanRSBarrettDMPhotoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomesJ Urol20051744 Pt 11344134816145416
- SaricaKAlkanELuleciHTasciIPhotoselective vaporization of the enlarged prostate with KTP laser: long-term results in 240 patientsJ Endourol200519101199120216359215
- AlivizatosGSkolarikosAChalikopoulosDTransurethral photoselective vaporization prostatectomy versus transvesical open enucleation for prostatic adenomas >80 ml: 12-mo results of a randomized prospective studyEur Urol200854242743718069117
- SpalivieroMArakiMWongCShort-term outcomes of Greenlight HPS laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH)J Endourol200822102341234718937595
- Bouchier-HayesDMVan AppledornSBugejaPCroweHChallacombeBCostelloAJA randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy with a 1-year follow-upBJU Int2009105796496919912196
- RuszatRSeitzMWylerSProspective single-centre comparison of the 120-W diode pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasiaBJU Int2009104682082519239441
- SpalivieroMArakiMCulkinDIncidence, management, and prevention of perioperative complication of GreenLight HPS laser PVP: experience in first 70 patientsJ Endourol20092349550219265468
- Al-AnsariAYounesNSampigeVGreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-upEur Urol201058334935520605316
- BachmannATubaroABarberN80-W XPS Greenlight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: 6-month safety and efficacy results of a European multicentre randomised trial – the GOLIATH studyEur Urol201465593194224331152
- BachmannATuberosABargerNEuropean multicenter randomized no inferiority trial comparing 180 W Greenlight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH studyJ Urol201593570578
- de la RosetteJElhilaliMNaitoSClinical Research Office of the Endourological Society Global GreenLight Laser Study: outcomes from a contemporary series of 713 patientsInt J Urol201522121124113026307430
- HueberPBienzMValdiviesoRPhotoselective vaporization of the prostate for benign prostatic hyperplasia using the 180 Watt system: multicenter study of the impact of prostate size on safety and outcomesJ Urol2015194246246925849599
- ThomasJTubaroABarberNA multicenter randomized non-inferiority trial comparing greenlight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: two-year year outcomes of the GOLIATH studyEur Urol2016699410226283011
- CimentepeEUnsalASaglamRRandomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: results at 18 monthsJ Endourol200317210310712689404
- MattiassonAWagrellLSchelinSFive-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter studyUrology2007691919617270624
- SeckinerIYessiliCAkdumanBAltanKMunganNAA prospective randomized study for comparing bipolar plasmakinetic resection of the prostate with standard TURPUrol Int200676213914316493215
- XiaSJZhuoJSunXWHanBMShaoYZhangYNThulium laser versus standard transurethral resection of the prostate: a randomized prospective trialEur Urol200853238239017566639
- KaplanSLeeJMeehanJTime course of incident adverse experiences associated with doxazosin, finasteride, and combo therapy in men with BPH: the medical therapy of prostatic symptoms (MTOPS) trialJ Urol20161951825182926678956
- FuWJHongBFYangYPhotoselective vaporization of the prostate in the treatment of benign prostatic hyperplasiaChin Med J (Engl)2005118191610161416232345
- NørbyBNielsenHVFrimody-MøllerPCTransurethral interstitial laser coagulation of the prostate and transurethral microwave thermo-therapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasiaBJU Int200290985386212460345
- US Department of Health and Human Services, Center for Medicare and Medicaid Services2016Part B National Summary Data File. [Data Set] Available from: https://www.cms.gov/Research-Statistics-Data-and-Systems/Downloadable-Public-Use-Files/Part-B-National-Summary-Data-File/Overview.htmlAccessed June 23, 2016
- US Department of Health and Human Services, Center for Medicare and Medicaid Services2014Part D Part D Prescriber Data CY2014 [Data Set]. Available from https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare-Provider-Charge-Data/PartD2014.htmlAccessed October 25, 2016
- Drugs.com Available from: www.drugs.comAccessed October 15, 2016
- Medscape.com Available from: www.medscape.comAccessed October 15, 2016
- US Department of Health and Human Services, Center for Medicare and Medicaid Services2014Part D Part D Prescriber Data CY2014 [Data Set]. Available from: https://www.medicaid.gov/medicaid/prescription-drugs/pharmacy-pricing/index.htmlAccessed November 2, 2016
- Walgreens.com Available from: www.walgreens.comAccessed October 16, 2016
- Walmart.com Available from: www.walmart.comAccessed October 16, 2016
- YuXElliottSPWiltTJMcBeanAMPractice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologiesJ Urol2008180124124518499180
- MalaebBSYuXMcBeanAMElliottSPNational trends in surgical therapy for benign prostatic hyperplasia in the United States (2000– 2008)Urology20127951111111622546389
- Table 2-18. Benign prostatic hyperplasia, lower urinary tract symptoms, bladder stonesLitwinMSSaigalCSUrologic diseases in America US Department of Health and Human Services, Public Health Service, National Institutes of Health National Institute of Diabetes and Digestive and Kidney DiseasesNIH Publication No. 12-7865Washington, DCUS Government Printing Office201262 Available from: https://www.niddk.nih.gov/about-niddk/strategic-plans-reportsAccessed December 15, 2017
- ThomasJATubaroABarberNThe continuing story of the cost-effectiveness of photoselective vaporization of the prostate versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic obstructionValue Health201518437638626091591
- ElhilaliMMElkoushyMAGreenlight laser vaporization versus trans-urethral resection of the prostate for the treatment of benign prostatic obstruction: evidence from randomized controlled studiesTransl Androl Urol20165338839227298788
- MamoulakisCEfthimiouIKazoulisSChristoulakisISofrasFThe modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostateWorld J Urol201129220521020461386
- ReichOGratzkeCBachmannAMorbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patientsJ Urol20121801246249
- OmarMILamTBAlexanderCESystematic review and meta-analysis of the clinical effectiveness of bipolar compared with monopolar transurethral resection of the prostate (TURP)BJU Int20141131243524053602
- RoehrbornCGBurkhardFCBruskewitzRCThe effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized studyJ Urol19991621929710379748
- WooHHGonzalezRRPerspective on the Rezūm® system: a minimally invasive treatment strategy for benign prostatic hyperplasia using convective radiofrequency water vapor thermal therapyMed Devices (Auckl)201710718028490907
- DixonCMCedanoERPacikDTwo-year results after convective water vapor energy treatment of symptomatic benign prostatic hyperplasiaRes Rep Urol2016820711627921028
- VerhammeKMDielemanJPBleuminkGSBoschJLStrickerBHSturkenboomMCTreatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph ProjectEur Urol200344553954514572751
- IssaMMLinPJEaddyMTShahMBDavisEAComparative analysis of alpha-blocker utilization in combination with 5-alpha reductase inhibitors for enlarged prostate in a managed care setting among Medicare- aged menAm J Manag Care2008145 Suppl 2S160S16618611090
- Quality Payment ProgramUnited States Department of Health and Human Services Available from: https://qpp.cms.gov/Accessed August 4, 2016